← brief for 2026-10-12 · Regeneration & devices

Carbocisteine Confers Renoprotection in Streptozotocin-Induced Diabetic Nephropathy Through Sirt-1/Nrf-2-Dependent Inhibition of NLRP3 Inflammasome Activation.

Key takeaways

This study found that a drug called carbocisteine protected the kidneys of rats with diabetes. It was done in animals, not people yet. The drug reduced inflammation and stress in the kidneys. More studies in people are needed to see if it works for them.

Who did this work

Nour OA · Samaha MM

Source

Article · PubMed, fibrosis reversal · 2026 Oct
https://pubmed.ncbi.nlm.nih.gov/42862046/